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Introduction
Autoimmune diseases, a group of 70 different diseases, repre-
sent the fifth leading cause of death by disease among females 
of reproductive age (1, 2). As suggested by several studies, vari-
ous components, such as genetic predisposition (sexual chromo-
somes, epigenetics, microchimerism, parental inheritance), hor-
monal factors, and environmental exposure, could underlie sexual 
dimorphism in autoimmune diseases. Sex hormones have been 
shown as main factors in disease triggering and development (3, 
4). The role of hormones has been described in the effector phase 
of autoimmune response, but not in the predisposition phase (5). 
For example, in systemic lupus erythematosus, estrogen favors 
survival of autoreactive B cells and skews their maturation toward 
a marginal zone phenotype (6). More generally, sex hormones play 
a role in the regulation of the balance of Th1/Th2 cytokines, with 
females more likely to develop a Th1 response, except during preg-
nancy, when Th2 response is predominant (7).
Autoimmunity is the result of tolerance breakdown, a phe-
nomenon occurring essentially in the thymus, the site of T cell 
education. In the thymus, T cells undergo positive and negative 
selections in contact with stromal cells. T cells expressing TCR 
that recognize the MHC/self-peptide molecule with high avid-
ity are deleted by apoptosis. Cells escaping this negative selec-
tion are potentially autoreactive and are involved in autoimmune 
disease development (8). The autoimmune regulator (AIRE), a 
transcription regulator expressed in medullary thymic epithelial 
cells (mTECs), is a key factor in the central tolerance and nega-
tive selection of autoreactive T cells. AIRE regulates the expres-
sion of tissue-specific antigens (TSAs). It has been involved in 
mTEC development and differentiation and could also induce a 
specific population of naturally occurring T-regulatory lympho-
cytes (Tregs) (9). The link between AIRE expression and autoim-
mune diseases has been demonstrated in humans and in animal 
models. In humans, mutations in the AIRE gene are responsible 
for an autosomal monogenic autoimmune defect called autoim-
mune polyendocrinopathy candidiasis ectodermal dystrophy 
(APECED). APECED patients display variable phenotype symp-
toms (10, 11) characterized by a combination of endocrine auto-
immune diseases, such as Addison’s disease, hypoparathyroidism, 
and type 1 diabetes. Mice deficient for Aire show high susceptibil-
ity to autoimmune diseases and increased autoreactive T cells in 
the periphery (12–14). Autoimmune destruction with cell infil-
trates in peripheral organs is also found in mice deficient for the 
AIRE protein (12, 15, 16).
Since the thymus is the site of central tolerance, we assumed 
that a comparison of the thymic transcriptome of males and 
females would reveal some secrets about potential differences in 
tolerance mechanisms that could shed light on increased female 
susceptibility to autoimmune diseases. This analysis of transcrip-
tome indeed revealed that AIRE-dependent TSAs were more 
expressed in males than in females, raising the hypothesis that 
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PCR performed on a total of 48 human thymuses, including prepu-
bescent child, pubescent child, and adult samples, revealed that as 
humans aged, AIRE expression decreased substantially. However, 
the time curves were different for females compared with males, 
with strong decreased expression of AIRE in females at pubes-
cence (Figure 1A). Expression of AIRE was normalized to the whole 
amount of RNA (28S), and to keratin 5 (K5) and keratin 14 (K14), 
the main keratins of the thymic medulla. The difference between 
pubescent males and females was significant no matter what gene 
was used for normalization (Figure 1B). We then analyzed AIRE 
protein expression in thymic human sections by immunofluores-
cence and immunohistochemistry. We chose the D17 anti-AIRE 
antibody that has already been validated and characterized in sev-
eral articles in immunohistochemistry and flow cytometry studies 
AIRE is a key factor in female susceptibility to autoimmune disor-
ders. By analyzing in detail AIRE expression in human and mouse 
thymuses as a function of sex and age, its regulation by hormones, 
and the link between AIRE expression levels and mouse suscepti-
bility to autoimmune diseases, we validated our hypothesis.
Results
AIRE is less expressed in female than in male thymuses. We com-
pared the human thymic transcriptome of males and females and 
observed differences in TSA expression (Supplemental Figure 1 
and Supplemental Table 1; supplemental material available online 
with this article; doi:10.1172/JCI81894DS1). Since the expression 
of these TSAs is regulated by AIRE, we hypothesized that AIRE 
could be differentially expressed in males and females. Real-time 
Figure 1. Differential AIRE expression in normal thymuses according to sex. AIRE mRNA levels, normalized to 28S, in 48 human thymuses during the aging 
process (A). The prepubescent child group (5 months to 11 years old) included 8 females and 7 males; the pubescent child group (13 to 17 years old) included 9 
females and 11 males; the adult group (over 18 years old) included 5 females and 8 males. AIRE mRNA levels, normalized to 28S, K5, and K14 in thymuses of 
pubescent child (B). Representative pictures of a human thymus labeled with an anti-K14 antibody (red) and with an anti-AIRE antibody (green) (C) or puri-
fied goat IgG control (D). Arrows indicate AIRE+ cells. Images were acquired with a Zeiss Axio Observer Z1 inverted microscope. Number of cells expressing 
AIRE protein per mm2 of thymic total section (E) or thymic medullary region (F) of human thymuses (n = 4–8 thymuses per sex and age). Compared analysis 
by immunohistochemistry and immunofluorescence of number of cells expressing AIRE protein per mm2 of thymic medulla of pubescent child (G). P values 
were obtained using the nonparametric Mann-Whitney U test. *P < 0.05; **P < 0.01.
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more, analysis of AIRE protein expression in pubescent thymus 
was replicated using immunoperoxidase staining instead of immu-
nofluorescence, with other sections from the same samples (8 
males and 8 females). The results, expressed as number of cells per 
mm2 of thymic medulla (Figure 1G), confirmed the first observa-
tion. Detailed numbers of cells are given in Supplemental Table 2. 
Of note, interindividual variability was much higher at the mRNA 
level than at the protein level (Supplemental Table 3), which is like-
ly a consequence of mRNA regulation or clearance and the high 
stability of protein (commonly observed for other genes; ref. 20).
Aire is less expressed in female than male mouse thymuses. We 
wondered whether these changes in AIRE expression during 
(17–19). Our observations are in agreement with previous studies 
showing that AIRE expression is primarily restricted to medullary 
areas (ref. 12 and Figure 1C). The staining, limited to the nucleus 
of some epithelial cells, had the typical nuclear dot pattern (Figure 
1C). The specificity of the AIRE staining was confirmed with a puri-
fied goat IgG that did not show labeling (Figure 1D). The protein 
expression profile at different ages (prepubescent child, pubescent 
child, adult) was very similar to that observed for mRNA (Figure 
1E). Pubescent females had fewer AIRE+ cells than males regard-
less of the factor of normalization used, the surface of the whole 
thymic section (Figure 1E), the surface of the thymic medulla (Fig-
ure 1F), or the K14+ cell number (Supplemental Figure 2). Further-
Figure 2. Differential AIRE and TSA expression in normal and castrated mouse thymuses and sorted mTECs. Aire mRNA expression in male and female 
mouse thymuses, 6 to 8 weeks old, in 3 different mouse strains (C57BL/6, SJL, and C3H) n = 5–6 thymuses for each sex and strain. (A). Number of AIRE+ 
cells per mm2 of thymic sections (B), number of AIRE+ cells per mm2 of thymic medulla (C), and percentage of cells expressing the AIRE protein in K14+ 
in the thymic medullary area (D) of SJL mice aged of 6 to 8 weeks old by sex (n = 4–6 thymuses for each sex). mRNA expression of Aire (E), Chrna1 and 
thyroglobulin (thryog), 2 AIRE-dependent TSAs (F), and Gad67, an AIRE-independent TSA (G), in sorted mTECs from 6-week-old male and female C57BL/6 
mice (n > 4 thymuses per sex). Thymic mRNA levels of Aire, Chrna1, and thyroglobulin (H), number of AIRE-expressing cells per thymic section (I), and 
percentage of cells expressing the AIRE protein among K14+ cells in the thymic medullary area (J) of control and castrated SJL male mice (n = 4–6 thymuses 
per group). Aire mRNA levels were normalized to K5. P values were obtained using the nonparametric Mann-Whitney U test. For H, P values were obtained 
using the 1-way ANOVA test. *P < 0.05; **P < 0.01; ***P < 0.001.
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selecting the cells with a CD45–MHCII+UEA+ly51– phenotype, as 
previously described in the literature (refs. 24, 25, and Supplemen-
tal Figure 5). mRNA expression of Aire was lower in female com-
pared with male sorted mTECs (Figure 2E). To validate this lower 
expression of Aire in females, we also analyzed the expression of 2 
TSAs known to be regulated by AIRE, acetylcholine receptor alpha 
(Chrna1) (26–28) and thyroglobulin (29, 30). These AIRE-depen-
dent TSAs were also significantly decreased in female mTECs 
compared with male mTECs (Figure 2F). In contrast, AIRE-inde-
pendent TSA, glutamate decarboxylase 67 (Gad67) (refs. 31, 32, 
and Figure 2G), was not differently expressed in male or female 
mouse mTECs, validating our observations of whole thymuses. 
These results raised the hypothesis of the involvement of sexual 
hormones in thymic AIRE expression.
Therefore, we investigated the possibility of modulating Aire 
expression in vivo by modifying hormone levels. We proceeded 
by bilaterally castrating SJL male mice and analyzing thymic Aire 
expression 2 weeks after surgery. In castrated SJL male mice, 
we observed a significant decrease in Aire, Chrna1, and thyro-
globulin mRNA expression (Figure 2H) as well as in the number 
of AIRE+ cells per thymic section (Figure 2I) or normalized to 
K14-positive cells (Figure 2J).
Male castration has been reported by various authors to affect 
thymic cellularity (33) and to regenerate involuted thymus, hence 
reversing age-related thymic atrophy (34, 35). We observed in 
human aging also occurred in mice. Therefore, we extended 
mRNA analysis to various mouse strains known to show sexual 
dimorphism or susceptibility toward experimental autoimmune 
diseases. Interestingly, C57BL/6 and SJL females, which are more 
susceptible to autoimmune diseases compared with males (21, 22), 
expressed less Aire than their male counterparts (Figure 2A). Con-
versely, in C3H mice, which do not display autoimmune disease 
susceptibility (23) the differences in Aire mRNA levels between 
males and females was not significant (Figure 2A).
To confirm these results at the protein level, we counted the 
number of AIRE-expressing cells in the thymus sections of male 
and female SJL and C3H mice. The number of AIRE+ cells was 
higher in adult SJL males compared with females, irrespective of 
the normalization used, whole thymus section surface (Figure 2B), 
thymic medulla surface (Figure 2C), or the number of medullary 
K14+ cells (Figure 2D). Detailed numbers of AIRE-positive cells are 
given in Supplemental Table 4. Representative medullary areas of 
3 male and female mouse thymuses are shown in Supplemental 
Figure 3. In C3H mice, the number of AIRE+ cells was not different 
in males compared with females, irrespective of the normalization 
used, whole thymus section surface, or thymic medullary surface 
(Supplemental Figure 4).
In order to validate that the low level of Aire mRNA expres-
sion in female whole thymuses was due to a decreased expres-
sion in medullary TECs, we isolated and FACS sorted mTECs by 
Figure 3. Influence of sex hormones 
on AIRE and TSA expression in cul-
tured human TECs. Effects of estro-
gen, testosterone, progesterone, and 
DHT (1 nM) on the mRNA expression 
of AIRE, AIRE-dependent TSA (thy-
roglobulin), and AIRE-independent 
TSA gene (GAD67) in human primary 
TECs (A). Dose-effect of estrogen (B) 
and DHT (C) on the mRNA expression 
of AIRE, thyroglobulin, and GAD67 
in human primary TECs. Dose effect 
of DHT in the presence of estrogen 
(1 nM) on the mRNA expression of 
AIRE in human primary TECs (D). Dose 
effect of estrogen in the presence of 
DHT (1 nM) on the mRNA expression 
of AIRE in human primary TECs (E). 
n > 4 individual human thymuses. 
Results are means ± SEM in B and C. 
*P < 0.05; **P < 0.01; ***P < 0.005 to 
0.001, 1-way ANOVA.
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changes in thymic global size compared with male castration, but 
led to subtle effects on AIRE expression, possibly due to estrogen 
production by the adrenal gland and fat tissue, which may main-
tain estrogen in the mouse serum (38, 39).
Estrogen decreases AIRE expression in cultured human and mouse 
TECs. These results suggest that sex hormones could regulate thy-
mic AIRE expression in vivo. To investigate this hypothesis, we ana-
lyzed the in vitro effects of the main sexual hormones on AIRE and 
TSA gene expression in well-defined and validated primary human 
TECs from thymic explants, known to be enriched in mTECs (40, 
41), as shown in Supplemental Figure 7. Human TECs were subcul-
tured and treated with estrogen, testosterone, dihydrotestosterone 
male castrated thymuses, as previously reported in the literature 
(36, 37), a significant reduction in the medullary area (Supplemen-
tal Figure 6A). However, the number of medullary epithelial cells 
(K14+) was unchanged in the whole thymus section (Supplemental 
Figure 6B). Therefore, the decrease in Aire expression in castrated 
male mice was not due to the reduction of the medullary areas, 
nor to the reduction of mTEC number, but was likely due to a true 
diminution of Aire expression.
In female SJL mice, ovariectomy induced a slight increase in 
Aire mRNA expression (Supplemental Figure 6C), while AIRE pro-
tein levels were unchanged compared with those of control female 
mice (Supplemental Figure 6, D and E). Female castration induced 
Figure 4. Influence of estrogen on AIRE and TSA expression in cultured human TECs, human thymic tissue grafted to NSG mice, and mouse fetal thymic 
organ culture. Representative flow cytometry plot of estrogen effect (1 nM) on AIRE protein level in human primary TECs; the control isotype is shown (red 
histogram) (A). Effect of estrogen on the percentage of AIRE-positive cells (B) and AIRE fluorescence geometric mean (geomean) (C) in cultured human 
primary TECs. For each experiment, control untreated cells were normalized to 100 (n = 8–9). Effect of daily intraperitoneal injections of estrogen (200 μg) on 
AIRE, thyroglobulin, and GAD67 mRNA expression in human thymic tissue grafted to NSG female mice aged of 5 to 6 weeks (n = 8) (D). Effect of the mouse 
sex recipient on AIRE mRNA expression in human thymic tissue engrafted subcutaneously in NSG mice for 4 days (E) (n = 3 individual human thymuses) 
and 20 days (F) (n = 4 individual human thymuses). Effect of estrogen on the mRNA expression of Aire, in mouse fetal thymic organ cultures (G). Each point 
represents the mean value of an experiment using thymuses from 4 to 5 different fetuses. Representative picture of mouse FTOC labeled with anti-K14 
(red) and anti-AIRE (green) antibodies. Images were acquired with a Zeiss Axio Observer Z1 inverted microscope (H). Effect of estrogen (estro) (10–7 M) on the 
number of cells expressing AIRE protein in the mouse FTOC (I). Cont, control. P values were obtained using the 1-way ANOVA test (B and C), nonparametric 
Mann-Whitney U test for unpaired data (D and I), and the Wilcoxon test for paired data (E–G). *P < 0.05; **P < 0.01; ***P < 0.005 to 0.001.
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(DHT) (the main testosterone active metabolite), and progesterone 
at a physiological concentration (10–9 M). Estrogen and progester-
one markedly decreased mRNA expression of AIRE and AIRE-
dependent TSA (thyroglobulin), but not of AIRE-independent 
TSA (GAD67). Even though testosterone induced no effect, DHT 
stimulated expression of AIRE (Figure 3A). Human TECs were then 
treated with estrogen and DHT at different concentrations. Estro-
gen induced a significant decrease in the mRNA expression levels 
of both AIRE and thyroglobulin (Figure 3B). GAD67 mRNA expres-
sion did not decrease, irrespective of the concentration of estrogen 
(Figure 3B). In contrast, DHT tended to increase both AIRE and 
TSA expression (Figure 3C). Moreover, we performed an analysis 
of combined treatments with estrogen and DHT. We observed that 
DHT at a low dose has no effect on the reduced expression of AIRE 
induced by estrogens, while at the highest dose (10–8 M), it increased 
AIRE expression (Figure 3D). Conversely, estrogen reduced the 
Figure 5. Pathways involved in estrogen-induced downmodulation of thymic AIRE expression. In vitro effects of the estrogen agonist PPT (10 nM) and 
the ER antagonist ICI 182.780 (20 μM) on AIRE mRNA expression in TECs (n = 3–7) (A). Aire (B) and AIRE-dependent TSA (Chrna1, and thyroglobulin) (C) 
mRNA expression in male and female thymuses of ERα-KO mice (n = 4–6). Percentage of cells expressing the AIRE protein among K14+ cells (D), number 
of AIRE-expressing cells per mm2 of thymic section (E) and per mm2 of thymic medulla (F), of male and female ERα-KO mice (n = 3–4). Effects of 5-aza-
2′-deoxycytidine (5-aza-2′dC) (5 μM), a DNA methylation inhibitor, and trichostatin A (50 nM), a histone deacetylase inhibitor on AIRE mRNA expression 
in TEC cultures (G) (n = 3–4). Effect of estrogen (1 nM) (H) and DHT (1 nM) (I) on methylation site levels of CpG motifs in the human AIRE promoter in 
independent cultured human TECs (8 for estrogen and 6 for DHT). Representative methylation pattern of the CpG motifs within the human AIRE gene 
promoter in primary cultured TECs treated with 1 nM of estrogen or of DHT (J). Each bar represents the methylation of a single CpG motif. The arrows show 
methylation sites that appeared after estrogen treatment. P values were obtained using the 1-way ANOVA test (A and G), the Mann-Whitney U test for 
unpaired data (B–F), and the Wilcoxon test for paired data (H and I). *P < 0.05 to 0.01; **P < 0.001.
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overexpression of AIRE induced by DHT (1 nM) (Figure 3E), show-
ing that estrogen and DHT have opposing effects on AIRE mRNA 
levels. When both hormones were added at 10–9 M, the dominant 
effect was that of estrogen. These results suggest that DHT in males 
favors an upregulation of AIRE thymic expression. However, in 
females, estrogen downregulates it.
Since estrogen is the primary hormone regulated in females 
during puberty — a period when AIRE expression is differential-
ly expressed in human thymuses — these results prompted us to 
focus on estrogen effects on AIRE protein expression in TECs, 
engrafted human thymuses, and mouse fetal thymus organ cul-
tures (FTOCs). We showed that, in primary human TECs, both 
the percentage of AIRE+ cells and the fluorescence intensity of 
AIRE expression in AIRE+ cells were reduced by estrogen treat-
ment (Figure 4, A–C). The decreased number of AIRE+ cells may 
be explained by either a decreased level of AIRE under a thresh-
old that makes it undetectable or a reduced differentiation toward 
AIRE+ cells in the presence of estrogens.
The effects of estrogen were analyzed in human thymic frag-
ments grafted in immunodeficient mice treated with estrogen 
(Figure 4D), and the results confirmed the estrogen downregula-
tion effect observed in vitro. Furthermore, the impact of the sex 
of the mouse recipient on the modulation of AIRE expression lev-
els was investigated with different human thymuses engrafted in 
male and female NOD/SCID/IL-2Rγ–deficient (NSG) mice. Aire 
thymic mRNA levels were assessed at days 4 and 20. The sex of 
Figure 6. Modulation of AIRE thymic expression by AIRE-miRNAi and its effect on male susceptibility to EAT. Aire (A) and AIRE-dependent TSA (B) mRNA 
expression in SJL mouse thymuses at day 6 after scAAV9-miRNAi (850) injection (n = 4–5). Percentage of cells expressing the AIRE protein in the thymic sec-
tion area (C) of SJL mouse after AIRE scAAV9-miRNAi intrathymic injection (n = 4–6). SJL mice were immunized with 100 nmol of p2340 in CFA emulsion by 
subcutaneous injections 7 days after intrathymic injection of 2 different AIRE scAAV9-miRNAi. Sera were collected at day 30 and the levels of antibodies to 
the thyroglobulin peptide p2340 in male, female, and AIRE scAAV9-miRNAi treated-male SJL mice were assessed by ELISA (D) (n = 4–8 sera per group). Bilat-
erally castrated SJL male mice were thymectomized (TX) and received a subcutaneous injection of 1 μg of estradiol (E2) every 2 days, and were challenged for 
EAT. Sera were collected at day 30, and the levels of antibodies to the thyroglobulin peptide p2340 were assessed by ELISA (E) (n = 5–7 sera per group). Num-
ber of infiltrating CD8-positive cells per μm2 of thyroid (F) (n = 4–8 mice per group). Representative photographs of mouse thyroid immunostaining labeled 
with an anti-CD8 antibody (red) of nonimmunized and immunized mice (G) for EAT challenge. Images were acquired with a Zeiss Axio Observer Z1 inverted 
microscope (F). P values were obtained using the Mann-Whitney U test (A–C) and the 1-way ANOVA test (D–F). *P < 0.05; **P < 0.01; ***P < 0.001.
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regulation of AIRE expression by estrogen was dependent upon 
DNA methylation, but not histone acetylation. In order to confirm 
this hypothesis, we sequenced the AIRE promoter in primary cul-
tured human TECs treated with estrogen or DHT. The number of 
methylation sites significantly increased after estrogen treatment 
(Figure 5H), but was unchanged with DHT treatment (Figure 5I) 
compared with that in untreated cells. Analysis of AIRE methyla-
tion sites demonstrated that some methylation sites (site 4 or 5) 
were often found in primary cultured human TECs obtained from 
different human thymuses, while estrogen more frequently chal-
lenged the methylation of sites 32, 40, 41, or 42. Interestingly, an 
increased number of methylation sites with estrogen was observed 
in all TEC samples analyzed (n = 8). A representative example of 
estrogen and DHT treatments on AIRE promoter methylation sta-
tus is presented in Figure 5J.
Reducing Aire thymic expression in male mice increases their 
susceptibility to EAT. By the use of AIRE-deficient models, a link 
between AIRE and autoimmunity has been clearly established (45). 
However, the influence of AIRE expression levels and female pre-
disposition to autoimmunity remains unknown. We demonstrated 
in different in vivo and in vitro models that estrogen downregulat-
ed the expression of AIRE. We thus assume that AIRE downregu-
lation by sexual hormones, including estrogen, may contribute 
to the increased female predisposition to autoimmune diseases. 
To investigate further this hypothesis and as a proof of concept, 
we used an experimental autoimmune thyroiditis (EAT) mouse 
model (46, 47) known to have a higher prevalence in females and 
castrated males (48) compared with normal males. Since male cas-
tration induced a significant decrease in Aire mRNA expression 
(Figure 2H) and an increased male susceptibility to EAT (48), we 
wondered whether a link exists between these 2 observations. We 
chose to decrease Aire expression in the male thymus by express-
ing a specific artificial inhibitory microRNA (miRNAi) (49) using 
a self-complementary adeno-associated virus vector of serotype 
9 (scAAV9) (50) instead of modulating estrogen levels that would 
also modulate several immune components, including cytokines 
and immunoglobulins (51–53). The efficiency of 3 miRNAi (Sup-
plemental Table 5) in downregulating the expression of AIRE was 
the thymus recipient significantly affected Aire expression levels 
at day 20, but not at day 4 (Figure 4, E and F). This late effect is 
likely related to the limited vascularization of the graft under the 
skin in the first week after graft.
Finally, in mouse FTOCs, estrogen also induced a decrease in 
Aire expression at both the mRNA level (Figure 4G) and the pro-
tein level (Figure 4, H and I). Typical AIRE-positive cells could be 
visualized on FTOC sections (Figure 4H), and their cell numbers 
decreased in the presence of estrogens (Figure 4I). Altogether, 
these in vitro and in vivo data suggest that estrogen contributes 
substantially to the downregulation of AIRE and AIRE-dependent 
TSA expression in TECs.
Estrogen induces epigenetic changes in the AIRE promoter. Since 
estrogen is clearly involved in the regulation of AIRE in mouse and 
human TECs, we investigated its mechanism of action by study-
ing the involvement of ERα, the main ER isoform expressed in 
TECs (42). An ERα preferential agonist (PPT) mimicked estrogen 
effects on AIRE expression in human TECs. The ERα antagonist 
(ICI 182, 780) inhibited the effects of estrogen (Figure 5A). In 
vivo, ERα-KO (also known as Esr1–/–) female and male mice, with a 
C57BL/6 background, expressed the same levels of Aire and AIRE-
dependent TSA thyroglobulin and Chrna1 (Figure 5, B and C). 
These results were confirmed at the protein level (Figure 5, D–F) 
irrespective of the factor used for normalization. As described 
in Yellayi et al., the size of the medulla is reduced in these ERα-
KO mice, similarly in males and females (43), suggesting that the 
similar AIRE expression in male and female ERα-KO mice was not 
due to thymic structural changes (Supplemental Figure 8). These 
results indicate that estrogen regulated the thymic expression of 
AIRE through ERα receptors.
No complete estrogen-responsive element has been found 
in the AIRE promoter. However, constitutive AIRE expression is 
known to be modulated through DNA methylation and/or his-
tone acetylation modifications (44). Indeed, estrogen’s regulation 
of AIRE was completely blocked by 5-aza-2′-deoxycytidine, an 
inhibitor of DNA methylation (Figure 5G). There was no change 
in AIRE regulation in the presence of trichostatin A, an inducer of 
histone deacetylation (Figure 5G). These results suggest that the 
Figure 7. Schematic representation of sexual hormone crosstalk effect 
on tolerance mechanisms involved in autoimmune disease. The balance 
between estrogen and testosterone has effects on many genes involved 
in the effector phase of autoimmune diseases, namely IgG, cytokines, and 
chemokines as well as transcription factors expressed in Tregs (FoxP3) and 
Th17 (RoRγT) cells. Our data show that the balance between hormones 
regulates AIRE expression, with estrogens decreasing its level (Figures 
1–5). The level of AIRE affects the susceptibility to autoimmune diseases. 
This statement, which has largely been described in the literature, was 
confirmed here by specifically reducing the thymic expression of AIRE 
by intrathymic injection of AIRE-specific miRNAi (Figure 6). Red arrows 
indicate findings from this study.
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yet proved in vivo, has been suggested. This mechanism assumes 
that AIRE induces mTEC apoptosis and favors crosspresentation 
of TSA proteins present in apoptotic cells to thymic dendritic cells 
(56). In addition, AIRE has been shown to have additional func-
tions, as it is involved in mTEC differentiation and maturation, 
chemokine production, and Treg induction (9).
So far, deficient mouse models have provided clear informa-
tion on the role of Aire in central tolerance. Aire–/– mice develop 
cell infiltrates in peripheral tissues, associated with deposition 
of autoantibodies. In several models involving AIRE-dependent 
TSA, Aire–/– mice were more susceptible to spontaneous (57) or 
induced autoimmune diseases than WT mice (58, 59). Further-
more, Aire-deficient mice had Tregs that failed to prevent sponta-
neous experimental colitis (60).
Of course, not all TSAs are regulated by AIRE and not all 
autoimmune diseases are due to AIRE-dependent TSAs. Never-
theless, in several models, it appears that AIRE-deficient mice 
have an increased susceptibility to autoimmunity, even when the 
TSAs are AIRE-independent, suggesting the involvement of the 
additional functions of AIRE discussed above. In experimental 
autoimmune encephalomyelitis (EAE), a model induced by pro-
teolipid protein (PLP) or myelin oligodendrocyte glycoprotein 
(MOG), AIRE-independent TSAs, Aharoni et al. demonstrated 
that AIRE-deficient mice display defective Tregs that participate 
in induced autoimmune reactions (61). Kurisaki et al. reported 
that Aire–/– mice showed significant lymphocyte infiltration in the 
pancreas and stomach due to AIRE-independent autoantibody 
production (Pdia2) (62) suggesting that AIRE may regulate the 
survival of autoreactive T cells beyond transcriptional control of 
self-protein expression in the thymus (63). These studies highlight 
that the lack of AIRE results in high susceptibility to spontaneous 
and induced autoimmune diseases linked to autoreactive T cells 
(62, 64) or Treg involvement (60).
AIRE expression levels may indicate an autoimmune disease sus-
ceptibility status. Some data in the literature support the idea that 
the level of AIRE in the thymus is correlated with susceptibility 
to autoimmune diseases. Thymic Aire expression levels correlate 
with the expression of TSA genes (65) and also with T cell thymic 
deletion induced by antigen. Indeed, the loss of 1 copy of Aire sig-
nificantly reduces the thymic expression of the endogenous insu-
lin gene, resulting in a substantial increase in islet-reactive CD4+ 
T cells escaping thymic deletion and a dramatically increased pro-
gression to diabetes (13). Other models, such as collagen-induced 
arthritis, show that mice heterozygous for Aire exhibit a clinical 
response that is intermediate between that found in Aire–/– and 
WT mice (59). Our findings clearly support the idea of a direct 
link between levels of AIRE and susceptibility to autoimmune dis-
eases. Decreasing the level of AIRE specifically in the thymus of 
male mice led to an increased susceptibility to induced thyroid-
itis, as assessed by the level of antibodies to thyroglobulin, and the 
number of infiltrating cells in the thyroid. An additional concept 
related to this finding has been proposed recently. In nonobese 
diabetic mice, age-related downregulation of Aire expression in 
mTECs precedes the emergence of type 1 diabetes mellitus (66). 
By using a doxycycline-regulated transgene to target Aire expres-
sion in mouse mTECs, it has been confirmed that the time window 
of Aire deficiency (early age) is sufficient to increase susceptibil-
first assessed in vitro (Supplemental Figure 9); we then selected 
the most efficient miRNAi (AIRE iRNA 850 and AIRE iRNA 288) 
and produced them in scAAV9 vectors. We investigated efficacy of 
AIRE iRNA 850 in vivo to reach thymic stromal cells (Supplemental 
Figure 10) and to downregulate thymic Aire expression by quanti-
tative reverse-transcriptase PCR (qRT-PCR) analyses (Figure 6A). 
We also observed that AIRE-dependent TSAs, including thyro-
globulin, were decreased in the thymus of miRNAi-treated mice 
(Figure 6B). In addition, the decreased number of AIRE+ cells per 
surface of thymic section was observed by an immunohistochemis-
try analysis of the thymic sections (Figure 6C). Male mice injected 
with AIRE scAAV9-miRNA into the thymus displayed increased 
autoantibodies against thyroglobulin (Figure 6D).
To create an in vivo link among estrogen, AIRE, and autoim-
mune thyroiditis, we performed an experiment in which 4-week-
old male mice were castrated, and we evaluated the effects of 
estrogens, in the presence or absence of the thymus, on autoim-
mune thyroiditis. We observed, as previously shown by Okayasu 
et al. (48), that estrogen increased the level of anti-thyroglobulin 
antibodies in nonthymectomized mice. However, when the mice 
were thymectomized, the effect of estrogen was abolished (Figure 
6E). These results clearly demonstrate that the deleterious effect 
of estrogen was linked to the thymus. Taking into account our 
previous demonstration that estrogen reduced AIRE expression, 
we clearly show that estrogen, by downregulating thymic AIRE 
expression, can favor the emergence of autoimmunity, an effect 
undetectable in the absence of thymus.
In a thyroiditis mouse model, the thyroid infiltrates are com-
plex and include CD4+ and CD8+ T cells, F4/80+ macrophages, 
and B220+ B cells (54). Thyroid cell infiltrations were analyzed 
with CD8 and F4/80 markers and counted as described by 
Caturegli et al. (55). The number of CD8+ infiltrating cells was 
lower in males compared with females, but increased CD8+ infil-
trating cells were found in male mice treated with AIRE miRNAi 
compared with control miRNAi or with control male mice (Figure 
6, F and G). Similar results were obtained when using the F4/80 
marker (Supplemental Figure 11). These results indicate that the 
specific thymic decrease in AIRE expression in males made them 
similar to the females in regard to the development of EAT. These 
findings validate the hypothesis that low expression of Aire may 
influence female autoimmune diseases susceptibility.
Discussion
Our data demonstrate the critical role that estrogen plays in AIRE 
thymic expression (mRNA and protein) and the consequences in 
terms of autoimmune disease susceptibility. Our results shed light 
on why most autoimmune diseases occur after puberty in females, 
when estrogen levels increase and contribute a new piece to the 
autoimmune disease predisposition puzzle (Figure 7).
AIRE, TSAs, and tolerance. The thymus, the primary organ 
involved in lymphocyte education, plays a major role in the devel-
opment of immune central tolerance. AIRE is a transcription 
regulator expressed by mTECs that is essential for the induction 
of central tolerance and acts by regulating TSA expression. There 
is strong evidence that AIRE deficiencies result in altered AIRE-
dependent TSA expression that leads to perturbed negative selec-
tion of autoreactive thymocytes. One potential mechanism, not 
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lular immune response compared with males, they also tend to 
overreact to autoantigens and then become more susceptible to 
autoimmune diseases (7). Estrogen regulates different processes 
of the immune response, such as immune cell differentiation, 
cytokine production, cytokine receptor expression, and regulation 
of Ca2+ (5, 7). Even the regulation of sex differential gene expres-
sion in immune cells after puberty in mice is mediated through 
the estrogen pathway (75–77). These estrogen effects are medi-
ated through 2 nuclear receptors, ERα and ERβ, both expressed 
at various levels in most immune cells (T cells, TECs, dendritic 
cells, B cells). Using castrated mice and ERα-deficient mice, we 
demonstrated that estrogen, through ERα, affects mTEC function 
by reducing the expression of AIRE and then decreasing the level 
of TSAs involved in the tolerance process. Therefore, sexual hor-
mones not only affect immune effector functions, but also act at 
an upstream level by modifying levels of AIRE. This process could 
have a pronounced consequence upon the negative selection of 
autoreactive cells. This hypothesis is supported by our data show-
ing that the deleterious effect of estrogen on the autoimmune 
response is linked to the thymus. Although neonatal thymectomy 
is often associated with increased autoimmunity due to a defect 
in expansion and differentiation of Tregs (78, 79), the hormonal 
environment in specific conditions of timing and mouse strain 
could induce differential effects in the absence or the presence of 
the thymus. Indeed, our data show that, while estrogen increased 
antibodies to thyroglobulin in nonthymectomized mice, it had no 
effect when the mice were thymectomized, indicating that the 
deleterious effect of estrogen was essentially a central effect. In 
support of this hypothesis, similar findings were shown in several 
models of autoimmunity. First, in the model of PVG/c rats, estro-
gen administration resulted in partial suppression of thyroiditis in 
thymectomized and irradiated rats (80). Second, in the model of 
glomerulonephritis in NZB/NZW FI mice, estrogen increased the 
level of antibodies to poly A, but neonatal thymectomy abolished 
the overproduction of these antibodies (81).
Taking into account the links among estrogen, AIRE, thymus, 
and autoimmunity, one could expect the number of peripheral 
autoreactive cells to be higher in females than in males. Indeed, 
in experimental lupus-prone mice, the number of pathogenic 
reactive CD4+ splenic T cells was much higher in females than in 
males (82). In addition, data from over 500 individuals showed 
that females displayed a higher frequency of increased T cell reac-
tivity to immunodominant PLP peptides compared with males, 
particularly in individuals who do not have multiple sclerosis (MS) 
(83). These data could be explained by a lower expression of AIRE 
in the thymus of females compared with males. Combined with 
a higher number of thymic emigrants in females (84), the risk 
of developing autoimmune disease is therefore much higher in 
females than males.
In conclusion, our data provide another line of evidence in 
the complex picture of female sex-associated susceptibility bias to 
autoimmune diseases (Figure 7). We emphasize the role of female 
sex hormones. During puberty, estrogen downregulates thymic 
AIRE expression and may reduce the efficiency of the tolerance 
process regulated by AIRE, resulting in increased export of autore-
active cells compared with that in males. The equilibrium between 
autoreactive T cells and Tregs is accordingly tenuous and can, in 
ity to autoimmune diseases in adults (67). This fact emphasizes 
that the age-related perturbation of the negative selection process 
includes a reduced expression of AIRE and an increased autoim-
mune phenotype in mice (68), thereby validating our observa-
tions. We demonstrated that AIRE thymic expression is reduced 
in females compared with males, which supports females being 
biased toward a high susceptibility to autoimmune diseases. Fur-
thermore, we also demonstrated that sex differential AIRE expres-
sion occurred in mouse strains such as SJL or C57BL/6, which dis-
play autoimmune disease susceptibility in females.
In humans, several examples of decreased AIRE expression 
have been associated with autoimmune diseases: Omenn patients 
(with a mutation in the RAG gene) have reduced AIRE expression 
and autoimmune pathology (69). Thymoma patients frequently 
develop autoimmune diseases and have a defect in AIRE expres-
sion (70). A very recent manuscript shows that reduction in AIRE 
expression in the thymoma is more striking in thymoma patients 
with autoimmune diseases than in thymoma patients without 
autoimmune diseases (71). Furthermore, Down syndrome (DS) 
patients are highly susceptible to autoimmune diseases (72), and 
a quantification of the number of AIRE+ cells in the thymus of a 
Brazilian cohort of DS patients revealed a 2-fold reduced number 
of AIRE+ cells compared with that in controls (73). Interestingly, in 
an independent recent study from a Spanish cohort, similar results 
were observed. When the authors looked specifically at the levels 
of AIRE in the thymus of the individuals who had developed hypo-
thyroidism in the course of 20 years, the reduction (about 2-fold) 
in intrathymic AIRE expression was greater in DS individuals with 
hypothyroidism than in those without hypothyroidism. These data 
suggest that moderate changes in AIRE expression (and TSAs) can 
have a major impact on predisposition to autoimmunity (17).
Of note, patients presenting type 1 autoimmune polyglandular 
syndrome due to a genetic AIRE deficiency are similarly repre-
sented among males and females (74), emphasizing that suscep-
tibility to autoimmune disease sexual dimorphism disappears in 
the absence of functional AIRE. Together, these data from the lit-
erature along with our findings support a relationship between the 
level of AIRE and susceptibility to autoimmune diseases.
Physiological links among AIRE, estrogens, and autoimmunity. 
Our results contribute another piece of evidence to this AIRE/tol-
erance/autoimmune disease susceptibility puzzle (Figure 7). Our 
data support the idea that the main female sexual hormone, estro-
gen, downregulates the expression of AIRE in mTECs, increasing 
female susceptibility to autoimmune diseases. Interestingly, DHT 
increases the expression of AIRE, and experiments with both hor-
mones show that the balance between estrogen and DHT affects 
levels of AIRE, with estrogen reducing it and DHT increasing it, 
although the estrogen effect was dominant when both hormones 
were added at 10–9 M. In addition, the mechanisms of action are 
dissimilar: estrogen clearly acts by methylation of AIRE while 
DHT does not affect it. It is likely that DHT effects are mediated 
via an indirect mechanism through modulation of expression and/
or function of molecules contributing to the transduction pathway 
involved in AIRE expression. Estrogen levels rise during puberty, 
the period when female predisposition to autoimmune diseases 
is very high. Even though females during this period exhibit an 
enhanced immune capability, with stronger humoral and cel-
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Study approval. Human studies were approved by the local ethics 
committee (CPP Kremlin-Bicêtre, France: agreement no. 06-018; CCP 
Ile de France Paris 6, France: agreement no. C09-36). In accordance 
with the 2004 French Bioethics Law, informed consent was obtained 
from patients or their legal representatives. Animal studies were 
approved by the French Ministry of Agriculture Committee for Ani-
mal Use (NDM certificate 75-1817). All surgical procedures were per-
formed in accordance with NDM authorization from the French Min-
istry of Agriculture (agreement no. 1-63IUTCIFd-Chir-07) for surgery 
on small rodents. All animals were handled according to the Animal 
Care and Use of Laboratory Animal guidelines of the French Ministry 
of Research (study approval no. 02638-02). Refer to the Supplemental 
Methods for further description of the experimental procedures. All 
primers used in the study are described in Supplemental Table 6.
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predisposed individuals, become unbalanced and result in the 
development of autoimmune diseases in the presence of a trig-
gering external factor. In industrialized countries, the percentage 
of patients with autoimmune diseases is on the rise. This prompts 
an investigation of the role of increased estrogen-like molecules in 
the environment and phytoestrogen-rich diets.
Methods
Human samples. Human thymic fragments were obtained from 84 
immunologically normal male and female patients (5 months to 46 
years old) undergoing corrective cardiovascular surgery at the Marie 
Lannelongue Chirurgical Center (Le Plessis–Robinson, France). The 
samples were divided into 3 groups: the prepubescent child group 
(5 months to 11 years old) included 16 females and 15 males; the pubes-
cent child group (13 to 17 years old) included 17 females and 19 males, 
and the adult group (>18 years old) included 9 female and 12 males. 
Neonate thymuses (up to 4 months) were not included in the study, 
since they were shown to display specific hormonal changes (85). All 
tissue samples were fast-frozen in liquid nitrogen within 30 minutes 
of their excision from patients. The analysis of AIRE mRNA was per-
formed on 48 thymuses, and counting of AIRE+ cells was performed in 
36 additional thymuses.
Mice. C57BL/6, SJL, and C3H mice were purchased from Janvier 
Laboratory. ERα-KO mice (86), backcrossed on a C57BL/6 back-
ground (more than 10 generations), were from R. Habert’s mouse col-
ony (CEA, Fontenay-aux-Roses, France; material transfer authoriza-
tion no. 2010-036, Institut Clinique de la Souris, Strasbourg, France). 
Male and female mice were 3 to 10 weeks old (n ≥ 3 per age and sex). 
Male and female SJL mice at 5 weeks old were bilaterally castrated and 
allowed to recover for 2 weeks before being sacrificed for thymus anal-
ysis. Male SJL mice at 7 weeks old received a 10-μl intrathymic injec-
tion of a vector solution (8 to 10.1012 viral genomes per ml) and were 
allowed to recover for 1 week before being treated for EAT.
The experiment investigating the effect of castration and thymec-
tomy on EAT development is represented in Supplemental Figure 12. 
In this experiment, male SJL mice at 3 weeks old were first castrated 
and then allowed to recover for 1 week before being thymectomized. 
Mice were challenged for EAT 2 weeks after thymectomy. Following 
the castration surgery, male SJL mice were treated every 2 days with 
1 μg of estradiol by subcutaneous injection (80, 87).
Statistics. Comparisons among groups were performed using 
1-way ANOVA when more than 2 groups were compared, and para-
metric or nonparametric t tests for comparison between 2 groups 
(Wilcoxon test for paired data, and Mann-Whitney U test for 
unpaired values). Nonparametric tests were used throughout. P < 
0.05 was considered statistically significant. GraphPad prism was 
used for all statistical analysis.
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